Physician scientists from City of Hope, one of the largest cancer research and treatment organizations in the United States, found that people with metastatic kidney cancer who orally took a live biotherapeutic product called ...
Jun 28, 2024
0
44
Noninvasive sound technology developed at the University of Michigan breaks down liver tumors in rats, kills cancer cells and spurs the immune system to prevent further spread—an advance that could lead to improved cancer ...
Apr 18, 2022
1
2566
Metabolites produced by gut bacteria during digestion can be used to trigger an immune response against colorectal cancer cells, according to new University of Alberta research, published in Frontiers in Immunology, that ...
Sep 13, 2023
0
124
Could the response to cancer immunotherapy depend on bacteria that originate in the gut and travel to the tumor?
Mar 6, 2020
0
518
Naked mole-rats can live for an incredibly long time and have an exceptional resistance to cancer thanks to unique conditions in their bodies that stop cancer cells multiplying, according to new research.
Jul 2, 2020
2
286
Cancer treatment often takes a team of health professionals—oncologists, nurses, surgeons, radiologists, pathologists, and social workers—to coordinate and provide comprehensive support for patients. At NYU, dentists ...
Aug 3, 2022
0
4
An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at Tel Aviv University developed a noninvasive technology platform for gene delivery into breast cancer cells. The technique ...
Jun 24, 2020
0
675
Scientists have deciphered a key strategy of cancer cells that allows them to outfox the immune system and enhance the odds of their survival by employing a deadly "two-faced protein" that is reminiscent of a two-faced figure ...
A plant virus that infects legumes, called cowpea mosaic virus, has a special power that you may not have known about: when injected into a tumor, it triggers the immune system to treat the cancer—even metastatic cancer—and ...
Apr 28, 2022
0
1054
(HealthDay)—A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration.
Aug 4, 2021
1
110
